Combination targeted therapy provides durable remission for patients with CLL
A combination of ibrutinib and venetoclax was found to provide lasting disease remission in patients with newly diagnosed chronic lymphocytic
Read moreA combination of ibrutinib and venetoclax was found to provide lasting disease remission in patients with newly diagnosed chronic lymphocytic
Read moreResults from the Phase II cohort of the CodeBreaK 100 study showed that treatment with the KRAS G12C inhibitor sotorasib
Read moreAs more and more people around the world are getting vaccinated, one can almost hear the collective sigh of relief.
Read moreScientists at The Wistar Institute characterized an inhibitor that targets acetate metabolism in cancer cells. Cancer cells use acetate metabolism
Read morePatients with thyroid dysfunction are routinely treated with drugs to regulate the hormone imbalance. The effect of these drugs is
Read moreFox News Flash top headlines for August 13 Fox News Flash top headlines are here. Check out what’s clicking on
Read moreNew research from the University of California, San Francisco (USCF) and City of Hope in the July 2020 issue of
Read moreA team of scientists from Peter the Great St.Petersburg Polytechnic University (SPbPU) together with their colleagues developed a method of
Read more